vCLAP, a caspase-recruitment domain-containing protein of equine Herpesvirus-2, persistently activates the Ikappa B kinases through oligomerization of IKKgamma.

The research article discusses the role of the vCLAP protein derived from equine herpesvirus-2 in activating NF-kappaB, a protein complex responsible for controlling DNA transcription in mammalian cells, through a process involving IKK enzymes.

Understanding vCLAP and its role in cell regulation

• The article explores the E10 gene product of equine herpesvirus-2, known as vCLAP. This protein contains a caspase-recruitment domain, also known as CARD, and has been shown to trigger apoptosis (cell death) and the activation of an important protein complex, NF-kappaB, within mammalian cells.
• vCLAP has a similar cellular counterpart, the Bcl10/cCLAP protein, which performs the same functions in activating apoptosis and NF-kappaB.

Activation process involving IKK-dependent pathway

• Research indicates that vCLAP activates NF-kappaB via an IkappaB kinase (IKK)-dependent pathway, but the details of this process have not been fully understood.
• This study shows that vCLAP stably associates with the IKK complex through a direct binding to the C-terminal end of IKKgamma, one of the IKK enzymes.
• IKKgamma is deemed crucial for the capability of vCLAP to activate NF-kappaB, and this association promotes prolonged activation of the IKK enzymes.

Role of specific components in vCLAP-induced oligomerization

• The researchers found that when they enforced the oligomerization (forming a complex structure) of the specific section of vCLAP that interacts with IKKgamma, it can trigger NF-kappaB activation.
• Experimentally exchanging the C-terminal end of IKKgamma, which interacts with vCLAP, with the CARD of either vCLAP or Bcl10, created a molecule that was still capable of activating NF-kappaB in IKKgamma-deficient cells.
• These results suggest that the oligomerization of IKKgamma, which is mediated by the CARD of vCLAP, might be the underlying mechanism by which vCLAP works to activate NF-kappaB.